Results 131 to 140 of about 15,884 (195)

Case Report: A rare pediatric case of hepatitis B virus infection with acute disseminated encephalomyelitis/Guillain-Barré syndrome spectrum diseases. [PDF]

Front Pediatr
Li Y, Hu D, Shen X, Mao X.
europepmc   +1 more source

HBsAg loss in recipients with chronic hepatitis B after allogeneic hematopoietic stem-cell transplantation: a retrospective cohort study exploring kinetic dynamics. [PDF]

BMC Infect Dis
Wang Q, Huang P, Zhang Q, Liu Y, Zang Q, Zhu C, Wang Y, He Y.   +7 more
europepmc   +1 more source

Hepatitis B treatment response and factors associated with HBV treatment success: A population-based study in Rwanda. [PDF]

Hepatol Commun
Makuza JD, Law M, Ramji A, Jeong D, Puyat J, Aravindakshan A, Morrow RL, Adu PA, Nisingizwe MP, Cua G, Velásquez García HA, Berabose C, Tuyishime A, Janjua NZ.   +13 more
europepmc   +1 more source

Resolution of Hepatitis Delta Virus-Related Cryoglobulinemic Vasculitis With the Use of Bulevirtide. [PDF]

ACG Case Rep J
Geremicca G, Labanca S, Pasta A, Pieri G, Marenco S, Cariati S, Grossi A, Giannini EG.   +7 more
europepmc   +1 more source

Different nucleos(t)ide analogs in resected hepatitis B virus-associated hepatocellular carcinoma: a systematic review. [PDF]

Front Pharmacol
Qiu H, Zhang Y, Xu F, Xue S.
europepmc   +1 more source

Comparative effectiveness of tenofovir versus entecavir combined with peginterferon Alfa-2b for functional cure in HBeAg-negative chronic hepatitis B: a propensity score-matched analysis. [PDF]

BMC Infect Dis
Wang PP, Wu HS, Deng WJ, Wu Y, Zhang Y, Gao ZL, Mo ZS.   +6 more
europepmc   +1 more source

Investigation of the long-term effects of high-potency antiviral agents on aspartate aminotransferase-to-platelet ratio index and fibrosis index based on four factors: five-year outcomes in hepatitis B e-antigen-negative chronic hepatitis B patients. [PDF]

Rev Assoc Med Bras (1992)
Arslan M, Cavnar AM, Çetin Ş.
europepmc   +1 more source

Effects of Non-Alcoholic Fatty Liver Disease on Baseline Histology and 96-Week Entecavir Response in Treatment-Naïve Chronic Hepatitis B. [PDF]

Infect Drug Resist
Gu X, Yang W, Hu Y, Li Y, Zheng L, Jiang B.   +5 more
europepmc   +1 more source

Serum type III procollagen, procollagen V, tumour necrosis factor-a, interleukin-6 in liver cirrhosis after antiviral treatment. [PDF]

J Med Biochem
Li W, Liu X, Bi F.
europepmc   +1 more source

Effect of antiviral therapy on 3-year recurrence and prognosis of hepatocellular carcinoma after curative radiofrequency ablation. [PDF]

World J Gastrointest Oncol
Xu BG, Zhang X, Liu F, Li FH, Zhang X, Xiang HL, Liang J.   +6 more
europepmc   +1 more source